Search Results

Filter
  • 1-10 of  3,891 results for ""Antitubercular Agents""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

How Integrated Digital Tools Can Improve Tuberculosis Medication Adherence: A Longitudinal Study in China.

  • Authors : Wang X; Wuhan Institute for Tuberculosis Control, Wuhan Pulmonary Hospital, Wuhan, China.; Fu Q

Subjects: Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/therapeutic use ; Tuberculosis*/Tuberculosis*/Tuberculosis*/drug therapy ; Tuberculosis*/Tuberculosis*/Tuberculosis*/chemically induced

  • Source: Telemedicine journal and e-health : the official journal of the American Telemedicine Association [Telemed J E Health] 2024 Feb; Vol. 30 (2), pp. 490-498. Date of Electronic Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100959949 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Treatment outcomes of multidrug-resistant tuberculosis patients receiving ambulatory treatment in Shenzhen, China: a retrospective cohort study.

  • Authors : Lecai J; Department of Tuberculosis Control, Shenzhen Center for Chronic Disease Control, Shenzhen, China.; Department of Nephrology, Affiliated Bao'an Hospital of Shenzhen, The Second School of Clinical Medicine, Southern Medical University, Shenzhen, Guangdong, China.

Subjects: Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/therapeutic use ; Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/drug therapy ; Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/epidemiology

  • Source: Frontiers in public health [Front Public Health] 2023 Jun 20; Vol. 11, pp. 1134938. Date of Electronic Publication: 2023 Jun 20 (Print Publication: 2023).Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Cost-Effectiveness Analysis of Combined Chemotherapy Regimen Containing Bedaquiline in the Treatment of Multidrug-Resistant Tuberculosis in China.

  • Authors : Xu CH; National Center for Tuberculosis Control and Prevention, China CDC, Beijing 100226, China.; Qiu YP

Subjects: Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/therapeutic use ; Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/drug therapy; Adult

  • Source: Biomedical and environmental sciences : BES [Biomed Environ Sci] 2023 Jun 20; Vol. 36 (6), pp. 501-509.Publisher: Chinese Center for Disease Control and Prevention Country of Publication: China NLM ID: 8909524 Publication Model:

Record details

×
Academic Journal

[Diagnosis and Treatment Outcomes and Influencing Factors of Multidrug-Resistant Tuberculosis Based on Patient Pathway].

  • Authors : Ren YL; School of Public Health,Hangzhou Normal University,Hangzhou 311121,China.; Chen B

Subjects: Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/therapeutic use ; Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/diagnosis ; Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/drug therapy

  • Source: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae [Zhongguo Yi Xue Ke Xue Yuan Xue Bao] 2023 Apr; Vol. 45 (2), pp. 178-184.Publisher: Zhongguo yi xue ke xue yuan Country of Publication: China NLM ID: 8006230 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Digitizing tuberculosis treatment monitoring in Wuhan city, China, 2020-2021: Impact on medication adherence.

  • Authors : Zhang M; Institute for Tuberculosis Control and Prevention, Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, China.; Wang G

Subjects: Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/therapeutic use ; Tuberculosis, Pulmonary*/Tuberculosis, Pulmonary*/Tuberculosis, Pulmonary*/drug therapy; Humans

  • Source: Frontiers in public health [Front Public Health] 2023 Mar 01; Vol. 11, pp. 1033532. Date of Electronic Publication: 2023 Mar 01 (Print Publication: 2023).Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Effect of a modified regimen on drug-sensitive retreated pulmonary tuberculosis: A multicenter study in China.

  • Authors : Ge Q; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.; Ma Y

Subjects: Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/therapeutic use ; Tuberculosis, Pulmonary*/Tuberculosis, Pulmonary*/Tuberculosis, Pulmonary*/drug therapy; Humans

  • Source: Frontiers in public health [Front Public Health] 2023 Jan 26; Vol. 11, pp. 1039399. Date of Electronic Publication: 2023 Jan 26 (Print Publication: 2023).Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

The dynamic impacts of environmental-health and MDR-TB diseases and their influence on environmental sustainability at Chinese hospitals.

  • Authors : Dai Z; Institute for Development of Central China /Wuhan University, Wuhan, 430072, China.; Sadiq M

Subjects: Antitubercular Agents* ; Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/drug therapy ; Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/epidemiology

  • Source: Environmental science and pollution research international [Environ Sci Pollut Res Int] 2022 Jun; Vol. 29 (27), pp. 40531-40541. Date of Electronic Publication: 2022 Mar 30.Publisher: Springer Country of Publication: Germany NLM ID: 9441769 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1614-7499

Record details

×
Academic Journal

Association of ABCG2 polymorphisms with susceptibility to anti-tuberculosis drug-induced hepatotoxicity in the Chinese population.

  • Authors : Wang N; Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, PR China.; Chen X

Subjects: Antitubercular Agents* ; Chemical and Drug Induced Liver Injury*; ATP Binding Cassette Transporter, Subfamily G, Member 2

  • Source: Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2022 May; Vol. 52 (5), pp. 527-533. Date of Electronic Publication: 2022 Jul 04.Publisher: Informa Healthcare Country of Publication: England NLM ID: 1306665 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Risk factors associated with unsuccessful tuberculosis treatment outcomes in Hunan Province, China.

  • Authors : Gilmour B; Faculty of Health Sciences, Curtin University, Bentley, WA, Australia.; Xu Z

Subjects: Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/therapeutic use ; Tuberculosis*/Tuberculosis*/Tuberculosis*/drug therapy ; Tuberculosis*/Tuberculosis*/Tuberculosis*/epidemiology

  • Source: Tropical medicine & international health : TM & IH [Trop Med Int Health] 2022 Mar; Vol. 27 (3), pp. 290-299. Date of Electronic Publication: 2022 Feb 06.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 9610576 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Factors predicting self-report adherence (SRA) behaviours among DS-TB patients under the "Integrated model": a survey in Southwest China.

  • Authors : Zhang R; Department of Social Medicine and Health Service Management, Army Medical University (Third Military Medical University), Chongqing, China.; Pu J

Subjects: Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/therapeutic use ; Tuberculosis*/Tuberculosis*/Tuberculosis*/drug therapy; Adult

  • Source: BMC infectious diseases [BMC Infect Dis] 2022 Mar 01; Vol. 22 (1), pp. 201. Date of Electronic Publication: 2022 Mar 01.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

×
  • 1-10 of  3,891 results for ""Antitubercular Agents""